HCA Healthcare, Inc. (HCA): Is It Time To Start A Correction

The stock of HCA Healthcare, Inc. (NYSE:HCA) has been Upgraded to Neutral from Underperform by BofA/Merrill in its latest research note that was published on September 06. HCA was given a price target of $137 by BofA/Merrill, with other Wall Street analysts also giving their reports regarding the stock. Goldman analysts bumped their recommendation on HCA stock from Neutral to Buy in a separate flash note to investors on July 10. Analysts at Raymond James issued an upgrade fromMkt Perform to Outperform for the stock, in a research note that dated back to April 23.

HCA Healthcare, Inc., which has current market capitalization of above $43 Billion, published its last quarter earnings on June 30, 2019.

HCA surged by $1.22 during the normal trading session on Thursday and reaching a high of $132.49 during the day while it closed the day at $128.69. The HCA stock had a low trading volume of 1.13 million shares on that day, which is low compared to the average daily volume of 1.57M shares. HCA has also gained 3.57% of its value over the past 7 days. However, the stock has surged by 1.03% in the 3 months of the year. Over the past six months meanwhile, it has lost 2.34% while it has added 3.41% year-on date. Let us now take a look at the stock’s potential support and resistance levels. The publicly traded company was seen to have slipped by -12.43% from its 3 months high price. However, taking another look at HCA will indicate that it is trading +10.34% away from its 90-day low. Looking at the bigger picture, the HCA Healthcare, Inc. stock has dropped by -12.71% from its 52-week high while it has surged by +16.66% from its 52-week low price.

On August 13, 2019 Whalen Kathleen M, SVP & Chief Ethics Officer sold 977 shares of the company. The average price for that transaction was $127.56 per share, which meant that Whalen Kathleen M earned $124626.1 selling the stocks. The sale was made public, with the document of the transaction filed with the SEC. Another insider trading occurred, with 10% Owner, Elcan Patricia F purchasing 250 shares of this stock on August 06, 2019. The average purchasing price for the stock was $124.1 per share, with the purchased stock accruing $31025. Following this transaction, the 10% Owner Elcan Patricia F now holds 997017 shares of the company, which is worth around $131000000.

HCA has around 2 Trillion cash on their books at the moment. This figure will have to be compared and looked into, with their current liabilities standing at $9 Trillion. The HCA stock is bringing in revenue of over 12 months, which is roughly 10 Trillion. Despite all that, HCA Healthcare, Inc. is seeing things progressing very much as their y-o-y quarterly revenue surged by 9.07%.

Looking at the stock’s Technical analysis information over the past 50 days shows that its Raw Stochastic average stood at 39.76%. This figure is worse than the company’s 20-day Raw Stochastic average which currently stands at 76.04%. Over the past 20 days, HCA’s Stochastic %K stood at 91.48% while its Stochastic %D was revealed to be 91%.